| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699464 | Clinical Oncology | 2008 | 4 Pages |
Abstract
Further evaluation of a five-fraction regimen of adjuvant whole breast radiotherapy in a phase III randomised trial is justified, including a regimen delivered in a total of 5 days.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Martin, M. Mannino, A. Rostom, D. Tait, E. Donovan, S. Eagle, J. Haviland, J. Yarnold,